European Registry of Transcatheter Repair for Tricuspid Regurgitation

Recruiting Observational Study
Tricuspid Regurgitation Valvular Heart Disease Heart Failure
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
3,000 (estimated)
Sponsor
LMU Klinikum · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

To investigate clinical and survival outcomes following transcatheter tricuspid valve repair or replacement.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients treated with one of the following transcatheter devices for TV repair or replacement: PASCAL, TriClip, TricValve, Evoque, LuX-Valve * Age ≥ 18 years
Contacts

Jörg Hausleiter, Prof. Dr.

+49 89 4400 72360

Joerg.Hausleiter@med.uni-muenchen.de

CONTACT

Lukas Stolz, Dr.

Lukas.Stolz@med.uni-muenchen.de

CONTACT